関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Omeprazole | HCID 4594 | — |
| 反応物 | m-Chloroperbenzoic acid | HCID 70297 | — |
| 反応物 | Timoprazole | HCID 72171 | — |
| 反応物 | 2-((pyridin-2-ylmethyl)thio)-1H-benzo[d]imidazole | HCID 683949 | — |
| 溶媒 | Chloroform | HCID 6212 | — |
| 生成物 | 3-Chlorobenzoic Acid | HCID 447 | — |
反応手順
5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole (omeprazole) was disclosed for the first time in U.S. Pat. No. 4,255,431. In the process of preparing 2-(2-pyridylmethylsulfinyl)benzimidazole compounds there is mentioned an oxidation of corresponding 2-(2-pyridylmethylthio)benzimidazole compounds with 3-chloroperoxybenzoic acid in a chloroform solution under stirring and cooling at a temperature under 5° C. 3-chlorobenzoic acid formed is then filtered off, the filtrate is diluted with methylene chloride, washed with Na2CO3, dried with Na2SO4, evaporated in vacuo and the residue is crystallized under addition of CH3CN. Since omeprazole is unstable in an acidic medium, the cooling of the reaction mixture to 5° C. is necessary to prevent a decomposition of the omeprazole formed.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US06268502B1 |
|---|
| 出典データセット | uspto-grants-2001_07 |
|---|
| ORD ID | ord-870ea6c530364bcab1c884964fa1820a |
|---|
| 出典メモ | uspto-grants-2001_07 |
|---|